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Abstract
Background: Dihydrocapsiate (DCT) is a natural safe food ingredient which is structurally related to capsaicin from
chili pepper and is found in the non-pungent pepper strain, CH-19 Sweet. It has been shown to elicit the
thermogenic effects of capsaicin but without its gastrointestinal side effects.
Methods: The present study was designed to examine the effects of DCT on both adaptive thermogenesis as the
result of caloric restriction with a high protein very low calorie diet (VLCD) and to determine whether DCT would
increase post-prandial energy expenditure (PPEE) in response to a 400 kcal/60 g protein liquid test meal. Thirty-
three subjects completed an outpatient very low calorie diet (800 kcal/day providing 120 g/day protein) over
4 weeks and were randomly assigned to receive either DCT capsules three times per day (3 mg or 9 mg) or
placebo. At baseline and 4 weeks, fasting basal metabolic rate and PPEE were measured in a metabolic hood and
fat free mass (FFM) determined using displacement plethysmography (BOD POD).
Results: PPEE normalized to FFM was increased significantly in subjects receiving 9 mg/day DCT by comparison to
placebo (p < 0.05), but decreases in resting metabolic rate were not affected. Respiratory quotient (RQ) increased
by 0.04 in the placebo group (p < 0.05) at end of the 4 weeks, but did not change in groups receiving DCT.
Conclusions: These data provide evidence for postprandial increases in thermogenesis and fat oxidation secondary
to administration of dihydrocapsiate.
Trial registration: clinicaltrial.govNCT01142687
Introduction
Resting energy expenditure (REE) decreases in response
to caloric restriction [1-4]. In the obese, this decline in
REE results in a decreasing rate of weight loss during
periods of low calorie dieting. There have been attempts
to inhibit the adaptive decrease in energy expenditure
that occurs through aerobic exercise [5-7], but a pre-
vious study from our group [8] demonstrated that the
institution of aerobic exercise did not affect the adaptive
decrease in thermogenesis which is believed to be
mediated by a change in sympathetic nervous system
(SNS) activity.
Capsaicin from chili pepper is known to stimulate
thermogenesis through a central nervous mechanism,
b u ta td o s e sr e q u i r e dt oo b s e rve this metabolic effect
intolerable gastrointestinal side effects occur. Studies
suggest that capsinoids such as dihydrocapsiate (DCT)
found in the non-pungent CH-19 sweet pepper share
the positive metabolic characteristics of capsaicin with-
out inducing gastrointestinal side effects [9-13]. DCT
has a hot taste threshold estimated at approximately
1,000 times that of capsaicin, but both capsaicin and
DCT stimulate TRPV1 receptors in the gut which bring
about activation of the SNS, which can increase lipogen-
esis and thermogenesis [10]. Extracts of CH-19 sweet
have been shown to increase body temperature, oxygen
consumption, sympathetic nervous system activation,
and to lead to weight loss in two studies [11,14].
The present study was designed to examine the effects
of DCT on both adaptive thermogenesis as the result of
caloric restriction with a high protein very low calorie
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increase post-prandial energy expenditure (PPEE) in
response to a 400 kcal/60 g protein liquid test meal.
Subjects and methods
Subjects
The study was approved by the Institutional Review
Board of the David Geffen School of Medicine at the
University of California, Los Angeles. Healthy men and
postmenopausal women with body mass index (BMI)
between 27 and 35 kg/m
2 were recruited through inter-
net advertisement and campus flyers. Subjects were
excluded for conditions of type 2 diabetes or glucose
intolerance, significant weight loss within 3 months,
history of bariatric surgery, a history of alcohol or cigar-
ette use, eating disorders, depression treated with medi-
cations and chronic diseases other than controlled
hypertension and hypercholesterolemia. The study was
registered at clinicaltrial.gov, NCT01142687.
Study Protocol
Each subject gave informed consent prior to beginning
the study. At the screening visit medical history, physical
exam, electrocardiogram and fasting blood tests were
performed. All eligible subjects were then started on the
lead-in phase when all were instructed to consume
maintenance calories and record food intake for 7 days
to assure that they maintain constant weight within
1 kg. Subjects were then randomized double-blinded
into placebo, 3 mg or 9 mg DCT groups for 4 weeks.
Vital signs, anthropomorphic assessments, safety labs
and adverse events were assessed weekly. The blood
samples were sent to the UCLA Clinical Laboratory for
analysis. Body composition and indirect calorimetric
measurements are performed at day 0 and 28.
Supplements
The dihydrocapsiate capsules of 1 mg and placebo were
obtained from Ajinomoto Co (Ajinomoto Co., Inc.
Japan). Dihydrocapsiate was synthesized enzymatically
with vanillyl alcohol and 8-methylnonanoic acid. Fol-
lowing the esterification, filtration, extraction and eva-
poration are conducted. Refined rapeseed oil was used
to dilute dihydrocapsiate to adjust the concentration.
200 mg of concentration adjusted dihydrocapsiate was
packed in soft capsules, followed by drying. The placebo
capsules to be used for the control group were prepared
in the same manner as the dihydrocapsiate capsules.
The investigators and subjects were blinded to the
identity of the capsules. Each subject was instructed to
consume capsules containing either DCT or placebo
three times per day within 30 minutes before breakfast,
lunch and dinner in a manner designed to provide 0, 3,
or 9 mg of DCT per day.
Very Low Calorie Diet (VLCD)
The VLCD plan consisted of eight servings per day of a
very low calorie protein shake providing 100 kilocalories
and 15 grams of high quality protein (Pro-Cal, R-Kane
Products). Forty miliequivalent of K-Dur (potassium
chloride tablet) were provided to all the subjects at the
start of the meal plan and the dose was adjusted accord-
ing to the weekly safety labs to maintain the potassium
level within the normal range. Subjects consumed four
additional servings on testing day one and day 28.
Subjects were counseled by the registered dietician and
physician for product compliance and possible side
effects from the capsules.
Body composition
Body weight was measured using a calibrated electronic
scale and body composition was measured using an air
displacement body plethysmograph (BOD POD, Life
Measurements Instruments). Subject wore a swimsuit,
biking shorts and a swim cap during the measurement.
Indirect calorimetric measurement
At day 0 and 28, subjects arrived at the facility in a fast-
ing state. Basal metabolic rate (BMR) was obtained by
measuring oxygen consumption and carbon dioxide pro-
duction over 20 minutes using a Vmax hood (Cardinal
Systems) while subjects remained recumbent at room
temperature. Subject consumed a high protein test
liquid meal over twenty minutes providing 400 kilocal-
ories and 60 grams of protein. Oxygen consumption and
carbon dioxide production was measured hourly over
the next four hours for postprandial energy expenditure
(PPEE). PPEE were adjusted by fat free mass (FFM).
Statistical analysis
Statistical analyses were carried out using SAS version
8.0.02 and a p value of 0.05 specified for statistical signifi-
cance. For the evaluation of body weight and fat mass,
the changes from baseline among groups were evaluated
using 1-factor ANOVA. For the evaluation of changes in
PPEE/FFM and RQ, the differences in mean change at
each time point for different doses were evaluated using
a mixed model with the change as a response variable
and with dose, time point and dose-time point interac-
tion as fixed effects. For evaluation of changes in BMR,
the differences of mean changes with different doses
were evaluated by using a mixed model with changes as
response variables, and with doses as fixed effects.
Results
Baseline characteristics
Out of 58 subjects screened, 46 subjects met the eligibil-
ity criteria and were randomized into the study. They
were randomly assigned to receive three times per day
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The numbers of dropped subjects in the three groups
above were 4, 3, and 6 respectively. One subject was
withdrawn because of elevated blood pressure which
was an exclusion criteria not noted at the time of entry.
The remaining subjects were dropped due to lack of
dietary compliance with the VLCD program. None of
subjects withdrew as the result of any adverse reaction
to the study supplements. Thirty-three subjects com-
pleted the study.
The demographic data are shown in Table 1 and there
were no statistical differences among the groups. The
BMI of subjects ranged from 26.9 to 38 kg/m
2. Twenty-
eight (61%) subjects were White, 7 (15%) were Hispanic,
8 (17%) were Black, 2 (4%) were Asian, and 1(2%) was
Native American.
Change of body weight and body composition
All subjects lost significant amounts of weight over the
four weeks. The average weight loss was 4.7 ± 0.6, 5.3 ±
0.7, and 5.2 ± 1.1 kg respectively for placebo, 3 mg and
9 mg DCT groups. As shown in Figure 1A, there were no
significant differences in weight loss over the four weeks
of the study among the three groups. The results of fat
mass measured by BOD POD are shown in Figure 1B.
No difference in overall fat mass lose was observed
between the groups.
Basal metabolic rate
A ss h o w ni nF i g u r e2 ,t h e r ew a sn o ta n ys i g n i f i c a n t
change in BMR after 4 weeks of very low calorie diet in
the three groups. Variation with BMR in response to the
VLCD was observed in all three groups. (Figure 3). DCT
did not change the adaptive decrease in metabolic rate
secondary to VLCD.
Postprandial energy expenditure
All subjects increased PPEE/FFM at day 0 in response to
the test meal. There was no significant difference among
the groups. Compared with subjects in the placebo
group, there was an increase in PPEE/FFM at 1 hour at
day 28 for subjects in the 3 mg and 9 mg but only the
change in the 9 mg was statistically significant (p <
0.05) (Figure 4). When the average PPEE/FFM change
over the four hours after the test meal was compared
among the groups, there was a dose-dependent increase
i nP P E E / F F Ma td o s e so fD C T3a n d9m ga td a y2 8
and the average PPEE change in 9 mg DCT group was
significantly higher than the placebo group (Figure 5).
Respiratory quotient
The average respiratory quotient was 0.75 ± 0.02, 0.80 ±
0.02 and 0.76 ± 0.01 for placebo, DCT 3 mg and 9 mg
respectively. At day 28, there was an increase of in aver-
age post-prandial RQ of 0.04 for subjects receiving the
placebo while the DCT groups did not change. This
increase in RQ was significant in comparison with the
DCT groups consistent with decreased fat oxidation in
the placebo group (p < 0.05) (Figure 6)
Discussion
The capsinoids are found in all tested cultivars of the
Capsicum genus of plants which includes chili peppers
[15,16]. The capsinoids include capsiate, dihydrocapsiate,
and nordihydrocapsiate which are structural analogs of
the capsaicin, dihydrocapsaicin, and nordihydrocapsaicin
found in hot chili peppers. Capsaicin results in a hot
sensation in the oral cavity, but the capsinoids are not
perceived as hot because they are hydrolyzed as they
cross the oral mucosa. Capsinoids including dihydro-
capsiate stimulate thermogenesis in animals, and acti-
vate the neuronal TRPV1 receptors on vagal afferent
nerves in the intestine leading to increased sympathetic
nervous system activity with uncoupling of oxidative
phosphorylation leading to heat production [10,17].
In this small double-blinded, randomized, placebo
controlled trial, we found that the consumption of a non-
pungent capsiate supplement by overweight and obese
subjects significantly increased post-prandial energy
expenditure when combined with a high protein, very low
calorie diet on an outpatient basis. The increase is esti-
mated to be equivalent to an increase in daily energy
expendtiture of approximately 100 kcal for a 100 kg indivi-
dual. Hill et al using data from national surveys have esti-
mated that changing energy balance favorably by
100 kilocalories per day could prevent the secular trends
in weight gain observed in the U.S. population [18].
Total daily energy expenditure is composed of basal
metabolic rate, postprandial thermogenesis, and physical
activity thermogenesis. An adaptive reduction in EE in
response to energy restriction can be observed in any
component of total EE, traditionally divided into resting
and non-resting EEs (including physical activity and
non-exercise activity EEs), and thermic effect of food
[19]. However, these changes are usually observed in
resting EE in individuals undergoing dietary restriction
Table 1 Baseline characteristics
DCT
Placebo 3 mg 9 mg
Subject number 15 15 16
Age (y) 49.6 ± 2.3 51.3 ± 2.6 53.9 ± 2.5
Females 5 6 9
Weight (kg) 92.8 ± 3.4 87.8 ± 4.8 89.9 ± 3.4
BMI (kg/m
2) 30.9 ± 0.9 30.4 ± 0.7 31.3 ± 0.7
Resting metabolic
rate (kcal/d) 1730.9 ± 71.4 1658.1 ± 101.0 1649.9 ± 100.0
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Figure 1 Change of body weight (A) and fat mass (B). Fat mass was determined by BODPOD. Values are shown mean and SE.
Figure 2 Average basal metabolic rate (BMR) at day 0 to day 28.
Figure 3 Individual change of basal metabolic rate (BMR) from day 0 to day 28.
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vidual variation on the adaptive thermogensis in our
study subjects at 4 weeks. There were no significant
changes observed at the group level in any of our study
groups after 4 weeks of VLCD and DCT supplementa-
tion. Inoue et al. previously reported that a significant
increase of oxygen consumption was detected in the
subjects with BMI over 25 in resting status when they
ingested capsinoids for 4 weeks [12]. In this context, a
marked reduction of body weight by VLCD in this study
m a yh a v em o r ei m p a c to nr e s t i n ge n e r g ye x p e n d i t u r e
than that of capsinoids.
Subjects in all three groups lost significant amounts of
body weight and fat mass but there were no significant
differences observed in weight or fat loss among the
groups. The severe restriction of calorie intake in the
VLCD may have overshadowed any potential effects of
capsinoids. While there were prior investigations estab-
lishing the effects of capsaicin and capsiates on satiety,
the VLCD did not allow assessment of food intake as a
practical measure of effects on satiety [20,21].
In this clinical trial, the impact of capsiate supplemen-
tation was tested on an outpatient basis where compli-
ance with diet is always problematic and undoubtedly
influenced the observations made here. This small
Figure 6 Changes of average of respiratory quotient (RQ) from
1 h to 4 h during diet induced thermogenesis at Day 28.V a l u e s
are shown mean and SE. * represents a significant difference (P < 0.05)
when compared vs. placebo.
Figure 4 Post-prandial energy expenditure (PPEE) at day 0 (A) and day 28 (B). Change (from 0 h) in PPEE adjusted by fat free mass (PPEE/
FFM). FFM was determined by BODPOD. Values are shown mean and SE. * represents a significant difference (P < 0.05) when compared vs.
placebo.
Figure 5 Changes of average of energy expenditure adjusted
by fat free mass (PPEE/FFM) from 1 h to 4 h during diet
induced thermogenesis at Day 28. FFM was determined by
BODPOD. Values are shown mean and SE. * represents a significant
difference (P < 0.05) when compared vs. placebo.
Lee et al. Nutrition & Metabolism 2010, 7:78
http://www.nutritionandmetabolism.com/content/7/1/78
Page 5 of 6metabolic study was not designed to assess long-term
effects on weight and body composition.
It has been reported in several small clinical trials that
capsinoids suppress body fat accumulation [11,13,22].
Josse et al has recently reported that 10 mg of capsi-
noids resulted in a shift on substrate utilization toward
lipid [23]. Using indirect calorimetry, we observed that
DCT supplementation blunted the increase in post-
prandial respiratory quotient at day 28 seen in the pla-
cebo group suggesting that DCT increased fat oxidation.
Further studies are needed to assess the impact of the
predicted differences in energy expenditure related to
DCT supplementation on weight loss and weight main-
tenance in free-living populations.
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